Noninfectious Uveitis Affecting the Posterior Segment

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants [Phase 1, Phase 2]

  An ongoing Phase 1/2 study of REGN7041 for active noninfectious uveitis affecting the posterior segment in adults, currently not recruiting.

• FDA approval · 2022-12-19
  FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)

  The FDA approved a supplemental application for OZURDEX (dexamethasone intravitreal implant) from Allergan, Inc., resulting in labeling chan…

• FDA approval · 2011-06-02
  FDA Approved: RETISERT — Supplemental Application (Bausch & Lomb Incorporated)

  FDA approved a supplemental application for RETISERT (fluocinolone acetonide) by Bausch & Lomb Incorporated.